Evidence map›Paper›PMID 27261766›Full record

ArticleJAMA oncology2016

AR-V7 Protein in Circulating Tumor Cells-The Decider for Therapy?

R B Montgomery, Stephen R Plymate

Abstract readComment
PubMed Publisher
In one paragraph

Article in JAMA oncology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

R B MontgomeryDepartment of Medicine, University of Washington, Seattle2Puget Sound VA Health Care System, Seattle, Washington.
Stephen R PlymateDepartment of Medicine, University of Washington, Seattle2Puget Sound VA Health Care System, Seattle, Washington3Geriatric Research Education and Clinical Center PSVAHCS, Seattle, Washington.

Funding

TRANSCRIPTOME AND PROTEOME STRATIFICATION OF PROSTATE ADENOCARCINOMA PHENOTYPESP50CA097186 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PETER S NELSON · 2002 to 2026
$58.1M
NCI NIH HHS P50 CA097186
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Line, TumorDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticHumansNeoplastic Cells, CirculatingProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantProtein IsoformsReceptors, AndrogenSignal TransductionProtein IsoformsReceptors, Androgen

Identifiers

PMID27261766

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.